Overview

Comparison Between Low-dose Ketamine Infusion and Intravenous Morphine

Status:
Completed
Trial end date:
2020-06-20
Target enrollment:
0
Participant gender:
Female
Summary
Ketamine is an antagonist of N-methyl-d-aspartate (NMDA) receptor that not only abolishes peripheral afferent noxious stimulation, but it may also prevent central sensitization of nociceptors as shown in animal studies with excellent analgesic property even in subanesthetic doses. It is readily available and is being used currently, even by non-Anesthesiologists, to provide "sedation" for minor procedures.(.. Low-dose ketamine infusion in the perioperative period has shown to produce analgesia and decrease the requirements of opioid analgesics.. In obstetrics, it is being used as an adjunct to an inadequately functioning spinal anesthesia for caesarean section, as an induction agent for cesarean section and also to provide analgesia during labor in intermittent boluses.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Cairo University
Treatments:
Ketamine
Morphine
Criteria
Inclusion criteria:

The study will include 80 ASA physical status I, II patients with age between 18- 50 years
old scheduled for elective myomectomy under general anesthesia

Exclusion criteria:

Patients who refused to participate, ASA physical status III, IV, patients younger than 18
years or > 50 years old, BMI > 30, history of epilepsy. Patients having a history of
parenteral or oral analgesics within the last 24 hours before initiation of operation or
those having allergy to study agents will be excluded.

-